S&P Announces Changes to US Indices: WYE for BUD, SRCL for BUD, FLO for SCRL, DMND for FLO, LIFE for ABI, BIO for IVGN
More News related to ABI
- Ball to Acquire Four Beverage Packaging Plants From AB InBev
- The Bank of New York Mellon Appointed as Depositary Bank by Anheuser-Busch InBev
- Abcourt Closes a Non-Brokered Private Placement of $397,000
- Abcourt Closes a Non-Brokered Private Placement of $397,000
- Abcourt Mines Inc. Has Hired MI3 Communications Inc to Provide Market-Making Activities for Abcourt
More News related to BIO
- Strativa's Development Partner, BioAlliance Pharma, Submits Loramyc(R) NDA
- Bioalliance Pharma Submits Loramyc(R) NDA to US FDA And Announces a General Shareholders' Meeting to Amend Its By-Laws
- Bio-Rad Laboratories (BIO) Receives FDA Clearance for 2 New Multiplex Infectious Disease Serology Panels
- Bio-Rad Receives FDA Clearance for ToRC IgG and HSV-1 & HSV-2 IgG Kits on the BioPlex 2200 Multiplex System
- Northland Securities Initiates Coverage on Bio-Rad (BIO) with an Outperform
More News related to BUD
- Top 15 For 2008 (No. 14): M&A Wreckage
- Notable Mergers and Acquisitions of the Day 11/18: F, BUD, ONNN/MCHP/ATML
- Morning Movers 11/18: HP (HPQ) Up on Strong Prelim Results/Guidance; Yahoo! (YHOO) Jumps After Yang Exits
- InBev Completes Acquisition of Anheuser-Busch - New Stock Symbol 'ABI'
- After-Hours Move 11/17: XFMedia (XFML) Falls After Results, Stericycle (SRCL) Up On S&P 500 Nod
Wyeth (NYSE: WYE) will replace Anheuser-Busch Companies Inc. (NYSE: BUD) in the S&P 100, S&P MidCap 400 constituent Stericycle Inc. (NASDAQ: SRCL) will replace Anheuser-Busch in the S&P 500, S&P SmallCap 600 constituent Flowers Foods Inc. (NYSE: FLO) will replace Stericycle in the S&P MidCap 400, and Diamond Foods Inc. (NASDAQ: DMND) will replace Flowers Foods in the S&P SmallCap 600 after the close of trading on a date to be announced. Anheuser-Busch is scheduled to be acquired by S&P Global 1200 constituent InBev in a transaction that is still pending final approvals.
Life Technologies Corp. (NASDAQ: LIFE) will replace Applied Biosystems Inc. (NYSE: ABI) in the S&P 500, and Bio-Rad Laboratories Inc. (NYSE: BIO) will replace Invitrogen Corp. (NASDAQ: IVGN) in the S&P MidCap 400 after the close of trading on Friday, November 21. Invitrogen is acquiring Applied Biosystems in a transaction expected to close on or about that date, pending final approvals.The merged company will take the name Life Technologies Corp.
Related Categories
Corporate NewsHot List
Trader Talk
Stocks Mentioned
+19.35
-49.84Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
